Szostak Nobel prize in medicine

Jack W. Szostak, a geneticist at Harvard Medical School, is one of three co-winners of the 2009 prize.

Jack Szostak

Professor of genetics Jack W. Szostak has won the Nobel Prize in Physiology or Medicine with Elizabeth H. Blackburn (University of California, San Francisco) and Carol W. Greider (Johns Hopkins School of Medicine). The three scientists were recognized for their work on how chromosomes are protected by telomeres and the enzyme telomerase. Szostak's home page at Harvard Medical School details his recent work on the synthesis of life on earth: "the related challenges of understanding the origin of life on the early earth, and constructing synthetic cellular life in the laboratory." His lab home page is here; he is also a Howard Hughes Medical Institute investigator, and  has a biographical page there, emphasizing his current work on the origins of life and the re-creation of the first steps in biological synthesis. Harvard's Origins of Life Initiative is described here; Szostak is one of the affiliated faculty members.

According to the Nobel press release, the trio have solved a critical part of a fundamental problem in biology: "how the chromosomes can be copied in a complete way during cell divisions and how they are protected against degradation. The Nobel Laureates have shown that the solution is to be found in the ends of the chromosomes--the telomeres--and in an enzyme that forms them – telomerase."


The explanation continues:

The long, thread-like DNA molecules that carry our genes are packed into chromosomes, the telomeres being the caps on their ends. Elizabeth Blackburn and Jack Szostak discovered that a unique DNA sequence in the telomeres protects the chromosomes from degradation. Carol Greider and Elizabeth Blackburn identified telomerase, the enzyme that makes telomere DNA. These discoveries explained how the ends of the chromosomes are protected by the telomeres and that they are built by telomerase.


If the telomeres are shortened, cells age. Conversely, if telomerase activity is high, telomere length is maintained, and cellular senescence is delayed. This is the case in cancer cells, which can be considered to have eternal life. Certain inherited diseases, in contrast, are characterized by a defective telomerase, resulting in damaged cells. The award of the Nobel Prize recognizes the discovery of a fundamental mechanism in the cell, a discovery that has stimulated the development of new therapeutic strategies.

 

Related topics

You might also like

Harvard Alumni Affairs Databases Breached

The University is investigating the cyberattack, which may have compromised the personal information of alumni, donors, students, faculty, and staff.

Harvard Law School Releases Digital Archive of Nuremberg Trials

Thousands of documents chronicle the Nazi regime and the legal effort to exact justice.

Summers Takes Leave Amid Harvard Probe

Previously undisclosed Epstein links to Harvard affiliates leads to a University review.

Most popular

Harvard Symposium Tackles 400 Years of Homelessness in America

Professors explore the history of homelessness in the U.S., from colonial poor laws to today’s housing crisis

Harvard’s Class of 2029 Reflects Shifts in Racial Makeup After Affirmative Action Ends

International students continue to enroll amid political uncertainty; mandatory SATs lead to a drop in applications.

What Trump Means for John Roberts’s Legacy

Executive power is on the docket at the Supreme Court.

Explore More From Current Issue

Three book covers displayed on a light background, featuring titles and authors.

Must-Read Harvard Books Winter 2025

From aphorisms to art heists to democracy’s necessary conditions 

Wolfram Schlenker wearing a suit sitting outdoors, smiling, with trees and a building in the background.

Harvard Economist Wolfram Schlenker Is Tackling Climate Change

How extreme heat affects our land—and our food supply 

People gather near the John Harvard Statue in front of University Hall surrounded by autumn trees.

A Changed Harvard Faces the Future

After a tense summer—and with no Trump settlement in sight—the University continues to adapt.